Insulet (Nasdaq:PODD) announced a medical device correction for its Omnipod 5 automated insulin delivery system.
Acton, Massachusetts-based Insulet’s correction relates to an issue with the Omnipod 5 controller’s charging port and cable. The correction does not impact the Omnipod 5 pod, the previous-generation Omnipod Dash and Omnipod, or compatible Android smartphone devices with the Omnipod 5 app installed.
Get the full story at our sister site, Drug Delivery Business News.